Ann: MOU with Temasek-linked Innoventures - Orthopaedics in China, page-13

First 13 Last

Share
Profile

Follow
Drakemaster

162 Posts.

9

12/09/23

10:17

Post #: 69822266
Share

Originally posted by stevenjd: ↑

Dont know.

But you have to wonder about sellers sometimes. We are 1/10th the price we were in 2019 says the CEO, now at the pointy end, low cap, with china expansion agenda, and revenues growth occurring in other parts of the world. The nature of a better light bulb, one that does not have the infection complications of the incumbents, is going to develop organic momentum. Patient outcomes, better health, its not a hard pitch to make, and by referrals of doctors who are using it, are going to be both repeat sales, and sales agents in effect when they talk to their colleagues.

I can imagine the emotional journey that longer holders have endured, seeing value wiped off their paper in the last few years, but that is the risk of the fickle investor who is impatient, and shifts the price, until, having crossed that wilderness, that desert, and now makes the RVR weighted heavily to cheap entry, and catching the forward growth curve. We are 3-4 years on, with regulatory approvals in place, and moving ahead.

Sometimes a great product, that is valued well by the market initially, runs into head winds. That doesnt prevent it from catching a tail wind after it has been harbored for some time.

Not investment advice.

Expand

yeah sure, but the investment/equity landscape today is different. Likely to see higher rates to be the new norm. So fundamentals are key to price again - value over growth.

So I think we need to see better fundamentals before we expect a better SP. That entire fair value calculation in this environment has changed.

OSX Price at posting: 6.9¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

PXX

Polarx discovers thick sulphide mineralisation at Alaskan Cu project

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

PGD

Peregrine extends high-grade gold shoot, sniffs anomalism at WA's Tin Can

IBG

Ironbark eyes lithium and niobium opportunities with 7 new Brazilian projects

There are more pages in this discussion • 21 more messages in this thread...

First 13 Last

Add OSX (ASX) to my watchlist

(20min delay)
Last 5.6¢		Change -0.002(3.45%)		Mkt cap ! $6.414M

Open	High	Low	Value	Volume
5.6¢	5.8¢	5.6¢	$22.47K	394.6K

Buyers (Bids)

No.	Vol.	Price($)
3	586045	5.6¢

Sellers (Offers)

Price($)	Vol.	No.
5.7¢	52500	1

View Market Depth

No.	Vol.	Price($)
3	586045	0.056
6	206362	0.055
2	212000	0.054
2	34000	0.053
4	189690	0.052

Price($)	Vol.	No.
0.057	52500	1
0.058	20000	1
0.060	17543	1
0.061	18378	1
0.062	12924	1

Last trade - 16.10pm 26/06/2024 (20 minute delay)

OSX (ASX) Chart

Ann: MOU with Temasek-linked Innoventures - Orthopaedics in China, page-13

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Polarx discovers thick sulphide mineralisation at Alaskan Cu project

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

Peregrine extends high-grade gold shoot, sniffs anomalism at WA's Tin Can

Ironbark eyes lithium and niobium opportunities with 7 new Brazilian projects

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: MOU with Temasek-linked Innoventures - Orthopaedics in China, page-13

Top Stories

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Polarx discovers thick sulphide mineralisation at Alaskan Cu project

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

Peregrine extends high-grade gold shoot, sniffs anomalism at WA's Tin Can

Ironbark eyes lithium and niobium opportunities with 7 new Brazilian projects

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News